Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community - To The Moon

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LEGN Legend Biotech

Closed 08-27 16:00:00 EDT

20.50

-0.18

-0.87%

盘后20.60

+0.10+0.49%

19:30 EDT

High20.86	Low20.32	Vol1.02M
Open20.70	D1 Closing20.68	Amplitude2.61%
Mkt Cap3.99B	Tradable Cap1.87B	Total Shares194.49M
T/O20.86M	T/O Rate1.11%	Tradable Shares91.34M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"LEGN","market":"US","secType":"STK","nameCN":"Legend Biotech","latestPrice":20.5,"timestamp":1787860800000,"preClose":20.68,"halted":0,"volume":1016199,"hourTrading":{"tag":"盘后","latestPrice":20.6,"preClose":20.5,"latestTime":"19:30 EDT","volume":10079,"amount":206724.714681,"timestamp":1787873403917,"change":0.1,"changeRate":0.004878,"amplitude":0.018537},"delay":0,"changeRate":-0.008704061895551243,"floatShares":91341200,"shares":194488413,"eps":-0.500766,"marketStatus":"Closed","change":-0.18,"latestTime":"08-27 16:00:00 EDT","open":20.7,"high":20.86,"low":20.32,"amount":20863002.435569998,"amplitude":0.026112,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-0.500766,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1787904000000},"marketStatusCode":5,"adr":0,"adrRate":2,"listingDate":1591329600000,"exchange":"NASDAQ","adjPreClose":20.68,"preHourTrading":{"tag":"盘前","latestPrice":20.68,"preClose":20.68,"latestTime":"09:13 EDT","volume":1135,"amount":23598.613550000002,"timestamp":1787836412462,"change":0,"changeRate":0,"amplitude":0.021277},"postHourTrading":{"tag":"盘后","latestPrice":20.6,"preClose":20.5,"latestTime":"19:30 EDT","volume":10079,"amount":206724.714681,"timestamp":1787873403917,"change":0.1,"changeRate":0.004878,"amplitude":0.018537},"volumeRatio":0.60082,"impliedVol":0.5703,"impliedVolPercentile":0.4343},"requestUrl":"/m/hq/s/LEGN/wiki","defaultTab":"wiki","newsList":[{"id":"2662663757","title":"Will Legend Biotech’s (LEGN) Move to Q2 Profitability Reshape Its Investment Narrative?","url":"https://stock-news.laohu8.com/highlight/detail?id=2662663757","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662663757?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:31","pubTimestamp":1787689883,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation recently reported its second-quarter 2026 results, with revenue rising to US$387.5 million from US$255.1 million and net income turning to US$33.2 million from a net loss of US$125.4 million a year earlier.\nOver the first half of 2026, revenue increased to US$692.6 million while the company sharply reduced its net loss to US$21.1 million, highlighting a rapid improvement in profitability metrics.\nWith Legend Biotech’s latest quarter showing a shift to...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/will-legend-biotechs-legn-move-to-q2-profitability-reshape-i","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/will-legend-biotechs-legn-move-to-q2-profitability-reshape-i","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LEGN","AIPO","CHAT","BK4581","QTOC","ARTY","MEMS","AGIX","BK4585","CANC","VTHR","XBI","MEDI","BK4588","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660444987","title":"Legend Biotech (LEGN) Turns Profitable In Q2, Is The Stock Cheap?","url":"https://stock-news.laohu8.com/highlight/detail?id=2660444987","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660444987?lang=en_us&edition=fundamental","pubTime":"2026-08-19 17:19","pubTimestamp":1787131188,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) drew fresh attention after reporting second quarter 2026 results, with revenue of US$387.5 million and net income of US$33.2 million, compared with a net loss a year earlier.\nSee our latest analysis for Legend Biotech.\nLegend Biotech’s latest earnings and leadership change in July have come against a mixed share price backdrop, with a 1-year total shareholder return that declined 38.5% and a 3-year total shareholder return that declined 68.3%. Meanwhile, the year-to-date...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-turns-profitable-in-q2-is-the-stock-chea","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/legend-biotech-legn-turns-profitable-in-q2-is-the-stock-chea","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LEGN","BK4581","MEMS","BK4585","CANC","XBI","MEDI","BK4588","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660492462","title":"Legend Biotech Sets September 24, 2026 AGM With Expanded Equity Plan on Agenda","url":"https://stock-news.laohu8.com/highlight/detail?id=2660492462","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660492462?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:28","pubTimestamp":1787084916,"startTime":"0","endTime":"0","summary":"Legend Biotech ( ($LEGN) ) has issued an update. Legend Biotech has called its Annual General Meeting of shareholders for September 24, 2026, at it...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/legend-biotech-sets-september-24-2026-agm-with-expanded-equity-plan-on-agenda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/legend-biotech-sets-september-24-2026-agm-with-expanded-equity-plan-on-agenda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["MEMS","BK4505","BK4581","XBI","BK4139","BK4229","LEGN","MEDI","AGM","BK4588","BK4195","BK4585","CANC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660494190","title":"Legend Biotech Seeks Shareholder OK to Add 19.1 Million Shares to RSU Plan Reserve","url":"https://stock-news.laohu8.com/highlight/detail?id=2660494190","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660494190?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:03","pubTimestamp":1787083388,"startTime":"0","endTime":"0","summary":"Legend Biotech seeks shareholder OK to add 19.1 million shares to RSU plan reserveLegend Biotech seeks shareholder approval to amend its 2020 restricted shares plan, adding 19,100,000 ordinary shares ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL37LWfk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","BK4588","BK4139","CANC","LEGN","MEMS","MEDI","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660549416","title":"Legend Biotech Announces Annual General Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2660549416","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660549416?lang=en_us&edition=fundamental","pubTime":"2026-08-19 04:02","pubTimestamp":1787083332,"startTime":"0","endTime":"0","summary":"Legend Biotech announces annual general meetingLegend Biotech schedules its annual general meeting in Bridgewater, New Jersey on Sept. 24, 2026.Shareholders will receive the audited consolidated finan","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nNDL8s0gBD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","BK4585","BK4505","MEMS","MEDI","BK4139","BK4588","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660897469","title":"How Legend Biotech’s Q2 Profitability Jump and Interim CEO Shift Will Impact Legend Biotech (LEGN) Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2660897469","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660897469?lang=en_us&edition=fundamental","pubTime":"2026-08-18 16:27","pubTimestamp":1787041666,"startTime":"0","endTime":"0","summary":"Legend Biotech Corporation recently reported past second-quarter 2026 results, with revenue rising to US$387.5 million from US$255.1 million a year earlier and net income improving to US$33.2 million from a net loss of US$125.4 million, while the board also appointed Alan Bash as interim CEO effective July 24, 2026.\nAn interesting aspect of this report is that the company produced positive earnings per share of US$0.18 in the quarter, even though it still recorded a net loss of US$21.1...","market":"us","thumbnail":"https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6111000-choice2-main-header/1585186599552"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/how-legend-biotechs-q2-profitability-jump-and-interim-ceo-sh","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-legn/legend-biotech/news/how-legend-biotechs-q2-profitability-jump-and-interim-ceo-sh","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LEGN","VGFPF","RGLO","FEBU","PMDE","BK4581","BK4585","BK4211","BK4139","DECU","VOTE","JOYT","MEMS","BK4588","BK4505","ISBC","XBI","CANC","MEDI","GXDW"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484697","title":"Legend Biotech price target lowered to $78 from $80 at Barclays","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484697","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484697?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:00","pubTimestamp":1786964442,"startTime":"0","endTime":"0","summary":"Barclays lowered the firm’s price target on Legend Biotech (LEGN) to $78 from $80 and keeps an Overweight rating on the shares post the Q2 report. ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/legend-biotech-price-target-lowered-to-78-from-80-at-barclays-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/legend-biotech-price-target-lowered-to-78-from-80-at-barclays-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659516785","title":"Celcuity Posts Narrower-than-Expected Loss as R&D Costs Decreased","url":"https://stock-news.laohu8.com/highlight/detail?id=2659516785","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659516785?lang=en_us&edition=fundamental","pubTime":"2026-08-14 04:17","pubTimestamp":1786652236,"startTime":"0","endTime":"0","summary":"Celcuity posts narrower-than-expected loss as R&D costs decreasedOverviewUS biotechnology firm's Q2 adjusted loss per share beat analyst expectationsQ2 adjusted net loss also beat analyst expectations","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A15A:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4505","CELC","MEMS","LEGN","MEDI","BK4139","CANC","BK4007","OMER","BK4588","KURA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659151875","title":"CorMedix Beats Q2 Revenue Estimates on DefenCath Growth, Raises FY Adjusted Ebitda Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2659151875","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659151875?lang=en_us&edition=fundamental","pubTime":"2026-08-13 19:42","pubTimestamp":1786621337,"startTime":"0","endTime":"0","summary":"CorMedix beatsQ2 revenue estimates on DefenCath growth, raises FY adjusted EBITDA guidanceOverviewUS biopharma firm's Q2 revenue rose, beating analyst expectationsEPS for Q2 beat analyst expectationsC","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260813:nL1N44A0I7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CRMD","BK4585","CANC","BK4007","MEDI","MEMS","LEGN","BK4588","OMER","BK4139","BK4505"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659900195","title":"Oncology Device Maker RenovoRx's Q2 Revenue Surges, Raises FY Outlook","url":"https://stock-news.laohu8.com/highlight/detail?id=2659900195","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659900195?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:20","pubTimestamp":1786566051,"startTime":"0","endTime":"0","summary":"Oncology device maker RenovoRx's Q2 revenue surges, raises FY outlookOverviewTargeted oncology device maker's Q2 2026 revenue rose 115% yr/yr to record $909,000Company raised full-year 2026 revenue gu","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44911Q:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["RNXT","BK4505","BK4563","BK4588","BK4082","CANC","ICCM","BK4139","IMNM","LEGN","MEDI","BK4585","BK4539","MEMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659194900","title":"MaxCyte Q2 Revenue Beats Estimates","url":"https://stock-news.laohu8.com/highlight/detail?id=2659194900","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659194900?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:20","pubTimestamp":1786566040,"startTime":"0","endTime":"0","summary":"MaxCyte Q2 revenue beats estimatesOverviewUS cell engineering platform's Q2 revenue fell 15% yr/yr but beat analyst expectationsQ2 adjusted EBITDA loss was larger than analyst consensusCompany repurch","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44911J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["CANC","LEGN","BK4585","MEMS","MEDI","BK4539","PROK","BK4121","BK4139","QTRX","BK4505","MXCT","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659008519","title":"Kura Oncology Q2 Product Revenue Rises 57% on Komzifti Uptake","url":"https://stock-news.laohu8.com/highlight/detail?id=2659008519","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659008519?lang=en_us&edition=fundamental","pubTime":"2026-08-13 04:11","pubTimestamp":1786565467,"startTime":"0","endTime":"0","summary":"Kura Oncology Q2 product revenue rises 57% on KOMZIFTI uptakeOverviewU.S. cancer drugmaker's Q2 net product revenue rose 57% from prior qtr on KOMZIFTI uptakeTotal Q2 revenue grew yr/yr, driven by pro","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nL1N44910S:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","CANC","LQDA","LEGN","BK4505","MEMS","BK4139","KURA","BK4007","BK4585","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659907385","title":"Sector Update: Healthcare Stocks Advance Late Afternoon","url":"https://stock-news.laohu8.com/highlight/detail?id=2659907385","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659907385?lang=en_us&edition=fundamental","pubTime":"2026-08-13 03:58","pubTimestamp":1786564721,"startTime":"0","endTime":"0","summary":"Healthcare stocks were higher late Wednesday afternoon, with the NYSE Healthcare Index up 0.2% and the State Street Health Care Select Sector SPDR ETF  adding 0.3%.The iShares Biotechnology ETF  rose 0.5%.In corporate news, Merck  shares rose 2.4% after Daiwa upgraded the stock to outperform from neutral and raised its price target to $143 per share from $120.Cencora  said that certain Walgreens volume that was being serviced by the company, separate from the prime vendor agreement, has started moving outside the company from July 1. Meanwhile, Cencora said its prime vendor agreement remains unchanged and accounts for the majority of its business with Walgreens. Cencora shares fell past 5%.Legend Biotech  could see pressures from competition and recent leadership change, potentially weighing on Carvykti myeloma therapy strategy, Oppenheimer said. It downgraded Legend to perform from outperform. Shares fell 5.2%.Definium Therapeutics  shares rose 5% after the firm said its phase 3 trial","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU2461242641.AUD","LU1069347547.HKD","IBB","BK4529","BK4534","IE00BFTCPJ56.SGD","LU0208291251.USD","BK4588","LU2468319806.SGD","LU2361045086.USD","LU0234572021.USD","LU1093756168.USD","LU1989771016.USD","SG9999013999.USD","HRTS","LU1699723380.USD","LU0266013472.USD","XLV","LU2125154935.USD","IE00BLSP4239.USD","JDOC","SG9999015358.SGD","LU1093756325.SGD","LU0868494708.USD","LU1989772923.USD","COR","LU0265550359.USD","LU1941712264.USD","LU2360032135.SGD","SG9999004303.SGD","VHT","SG9999002232.USD","BK4516","LU0130517989.USD","LU0006306889.USD","LU0965509010.AUD","SG9999014567.USD","SG9999014575.USD","LABU","LU0965509101.SGD","LU1116320901.HKD","LU2089984988.USD","IE00B1BXHZ80.USD","LU0124676726.USD","LU0203347892.USD","SG9999002224.SGD","LU1066051498.USD","IE00BJJMRZ35.SGD","FHLC","SG9999015341.SGD","DFTX","LU2112291526.USD","LU1974910355.USD","IE00BJT1NW94.SGD","LU0965508806.USD","BK4559","LU1057294990.SGD","LU1066051811.HKD","LU2237957902.USD","PPH","LU1119994496.HKD","LU1116320737.USD","SG9999001440.SGD","LU0070302665.USD","LU0942090050.USD","LU1066051225.USD","IXJ","LU2125909593.SGD","IE000M9KFDE8.USD","MRK","LU1061106388.HKD","LU1923622614.USD","IE00BN8TJ469.HKD","MEDI","LU1585245621.USD","FTXH","LU0265550946.USD","BMED","LU0203345920.USD","LU0868494617.USD","LU2324357040.USD","LU1291159041.SGD","LU2491049909.HKD","LU0106261372.USD","PAWZ","LU0122379950.USD","BK4533","LU2125909247.SGD","LU2237957811.SGD","BK4550","LU0823416689.USD","IE0009355771.USD","LU1934455194.USD","LU1917777945.USD","LU0289739699.SGD","LU0861579265.USD","LU1261432733.SGD","LU0098860793.USD","LU2106854487.HKD","LU0648001328.SGD","IYH","BK4007","SG9999014559.SGD","LU0859254822.USD","LU1162221912.USD","SGXZ57979304.SGD","LU0320765489.SGD","LU1941712348.USD","LU0238689110.USD","LU2491050071.SGD","SG9999001176.SGD","BK4084","LU0058720904.USD","LU2361044949.HKD","CANC","BK4581","LU1929549753.HKD","LEGN","RXL","IE00BLSP4452.SGD","LU0320765646.SGD","LU2361044865.SGD","BK4175","LU0965509283.SGD","LU0980610538.SGD","GDOC","LU1201861249.SGD","LU0130102774.USD","LU2023250504.SGD","SG9999001176.USD","IE0002141913.USD","BK4139","LU1571399168.USD","IE00BSNM7G36.USD","LU2433249047.HKD","LU2491050154.USD","LU1066053197.SGD","LU2023250843.SGD","LU2357627491.SGD","LU1814569148.SGD","LU2125154778.USD","BK4505","LU0985320562.USD","SG9999014542.SGD","LU1037948897.HKD","LU1430594728.SGD","IE00B4R5TH58.HKD","LU0432979614.USD","LU1037948541.HKD","TRUH","LU1934455277.USD","LU0689626769.HKD","IE00B2B36J28.USD","LU1023059063.AUD","LU1084165304.USD","MEMS","LU0477156953.USD","BK4585","LU1035773651.USD","SGXZ23171101.USD","LU0211331839.USD","IE00BBT3K403.USD","LU1989772840.SGD","XBI","IHE","LU1983299246.USD","LU1934455863.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659053904","title":"Legend Biotech Shares Fall After Oppenheimer Downgrade","url":"https://stock-news.laohu8.com/highlight/detail?id=2659053904","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2659053904?lang=en_us&edition=fundamental","pubTime":"2026-08-13 02:20","pubTimestamp":1786558851,"startTime":"0","endTime":"0","summary":"Legend Biotech (LEGN) shares were down 5.6% in Wednesday trading after Oppenheimer downgraded the company's stock to perform from outperform.Trading volume stood at about 2 million shares, compared with a daily average of roughly 2.7 million.Price: 20.59, Change: -1.24, Percent Change: -5.68","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OPY","XBI","LEGN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658909519","title":"Legend Biotech Could See Pressures From Competition, CEO Transition, Oppenheimer Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658909519","media":"MT Newswires Live","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658909519?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:58","pubTimestamp":1786550316,"startTime":"0","endTime":"0","summary":"Legend Biotech  could see pressures from competition and its recent leadership change, potentially weighing on its Carvykti myeloma therapy strategy, Oppenheimer said in a Wednesday note.Chief Executive Ying Huang resigned from the company in July and his departure raised concerns over strategies as Anito-cel nears potential approval and commercialization as a competing myeloma treatment, the investment firm said.Anito-cel's approval could pressure Legend Biotech's stock and Carvykti's near-term growth, but Oppenheimer noted that it continues to expect Carvykti to corner a majority of the market share in multiple myeloma.Carvykti sales could still peak at about $5 billion, but its near-term position could depend on the new CEO's strategic vision, the brokerage said.Oppenheimer downgraded Legend Biotech to perform from outperform and adjusted the price target to $40 from $75.Price: 20.66, Change: -1.17, Percent Change: -5.36","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4581","XBI","BK4585","MEMS","BK4139","BK4588","BK4127","LEGN","OPY","CANC","BK4505","MEDI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658690574","title":"Legend Biotech Carvykti Growth, Profitability Outlook Remain Positive, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2658690574","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658690574?lang=en_us&edition=fundamental","pubTime":"2026-08-12 23:01","pubTimestamp":1786546891,"startTime":"0","endTime":"0","summary":"Legend Biotech  is positioned to sustain profitability after achieving adjusted net income profitability in Q2 and given its existing cash runway, RBC Capital Markets said.Revenue increased to $387.5 million from $255.1 million. Revenue growth was mainly driven by myeloma therapy Carvykti, according to the note Tuesday.Carvykti's market share as an earlier-line treatment for myeloma continues to grow. RBC said the 2nd-to-4th-line market remains underpenetrated by BCMA-targeting therapies.The investment firm believes near-term risk to Carvykti, developed in collaboration with Johnson & Johnson , from bispecifics and future CAR-T entrants is being overstated. The continued investment by Legend and J&J supports the drug's growth outlook, according to the note.Johnson & Johnson has reiterated Carvykti's potential to generate more than $5 billion in annual sales.RBC has an outperform rating on the stock and lowered its price target to $58 from $59.Shares of Legend Biotech were down 3.4% in ","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["MEMS","BK4588","LU0072461881.USD","JNJ","LU0689472784.USD","LU0098860793.USD","BK4533","MEDX","GDOC","TRUH","LU0787776722.HKD","RXL","IE00BSNM7G36.USD","LU1066053197.SGD","LU1989771016.USD","XLV","LEGN","LU0640476718.USD","LU0683600562.USD","LU2487616109.SGD","LU2602419157.SGD","IXJ","MEDI","FHLC","LU1244550577.SGD","VHT","IE000WAW04H5.SGD","XBI","LU2133065610.SGD","LU1145028129.USD","LU1196500208.SGD","JDOC","BK4585","FTXH","IYH","SGXZ57979304.SGD","BMED","LU1066051811.HKD","LU0943347566.SGD","LU0795875169.SGD","IHE","LU0124676726.USD","BK4007","LU1074936037.SGD","BK4532","CANC","PJP","LU2505996681.GBP","IE00BFTCPJ56.SGD","IE00BKVL7J92.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658903284","title":"Legend Biotech Price Target Cut to $58.00/Share from $59.00 by RBC Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2658903284","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658903284?lang=en_us&edition=fundamental","pubTime":"2026-08-12 22:16","pubTimestamp":1786544160,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/LEGN/analyst-ratings","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658977896","title":"Legend Biotech Corp. : Oppenheimer Cuts to Perform from Outperform","url":"https://stock-news.laohu8.com/highlight/detail?id=2658977896","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658977896?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:25","pubTimestamp":1786537513,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260812:nAZN4TDJGE:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4505","BK4588","CANC","BK4139","LEGN","MEDI","BK4585","MEMS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658720519","title":"Goldman Sachs Reaffirms Their Buy Rating on Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658720519","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658720519?lang=en_us&edition=fundamental","pubTime":"2026-08-12 20:19","pubTimestamp":1786537191,"startTime":"0","endTime":"0","summary":"Goldman Sachs analyst Ziyi Chen maintained a Buy rating on Legend Biotech today and set a price target of $40.70. According to TipRanks, Chen is a ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/goldman-sachs-reaffirms-their-buy-rating-on-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LEGN","XBI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658974863","title":"Analysts Offer Insights on Healthcare Companies: Vertex Pharmaceuticals (VRTX), Brookdale Senior Living (BKD) and Legend Biotech (LEGN)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658974863","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658974863?lang=en_us&edition=fundamental","pubTime":"2026-08-12 19:10","pubTimestamp":1786533037,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Vertex Pharmaceuticals (VRTX), Brookdale Senior Livi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-vertex-pharmaceuticals-vrtx-brookdale-senior-living-bkd-and-legend-biotech-legn-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["CANC","BK4532","LU1585245621.USD","LU1815336091.USD","GNMX","MEMS","TBXU","BK4185","BBH","SG9999001176.USD","LU1778281490.HKD","IE00B19Z3B42.SGD","IBB","XBI","LEGN","LU1430594728.SGD","SG9999001176.SGD","LU2237438978.USD","LU0757428866.USD","VERX","IBBQ","BIB","BK4588","IE0002270589.USD","LU1499592464.USD","VRTX","LABU","BKD","BK4505","LU2468319806.SGD","MEDI","LU0234570918.USD","LU0417517546.SGD","LU0432979614.USD","LU1674673691.USD","PBE","LU2089984988.USD","LU0029874061.USD","LU2462157665.USD","XLV","IE00B894F039.SGD","LU0058720904.USD","LU2417539215.USD","LU0061475181.USD","IE00BZ9MQY76.HKD","IDNA","HCSG","LU0079474960.USD","IE00B19Z3581.USD","LU1035775433.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.legendbiotech.com","stockEarnings":[{"period":"1week","weight":-0.085},{"period":"1month","weight":0.0732},{"period":"3month","weight":-0.2682},{"period":"6month","weight":0.0884},{"period":"1year","weight":-0.4105},{"period":"ytd","weight":-0.0488}],"compareEarnings":[{"period":"1week","weight":-0.0039},{"period":"1month","weight":0.0365},{"period":"3month","weight":0.0152},{"period":"6month","weight":0.1168},{"period":"1year","weight":0.1874},{"period":"ytd","weight":0.1234}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Legend Biotech Corp is a global, clinical-stage biopharmaceutical company engaged in the discovery and development of novel cell therapies for oncology and other indications. The company's differentiated technology, global development and manufacturing strategy and expertise provide it with the ability to generate, test and manufacture next-generation cell therapies targeting indications with high unmet needs.","yearOnYearQuotes":[{"month":1,"riseRate":0.333333,"avgChangeRate":-0.047546},{"month":2,"riseRate":0.5,"avgChangeRate":0.01776},{"month":3,"riseRate":0.333333,"avgChangeRate":-0.03136},{"month":4,"riseRate":0.833333,"avgChangeRate":0.112839},{"month":5,"riseRate":0.5,"avgChangeRate":0.032168},{"month":6,"riseRate":1,"avgChangeRate":0.13586},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.022064},{"month":8,"riseRate":0.285714,"avgChangeRate":-0.031211},{"month":9,"riseRate":0.166667,"avgChangeRate":-0.023313},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.000245},{"month":11,"riseRate":0.333333,"avgChangeRate":-0.020911},{"month":12,"riseRate":0,"avgChangeRate":-0.105244}],"exchange":"NASDAQ","name":"Legend Biotech","nameEN":"Legend Biotech","securityTypeName":"DR","adrRate":"1:2"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.48.0","shortVersion":"4.48.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Legend Biotech,LEGN,Legend Biotech股票,Legend Biotech股票老虎,Legend Biotech股票老虎国际,Legend Biotech行情,Legend Biotech股票行情,Legend Biotech股价,Legend Biotech股市,Legend Biotech股票价格,Legend Biotech股票交易,Legend Biotech股票购买,Legend Biotech股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Legend Biotech(LEGN),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Legend Biotech(LEGN) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}